BiotechTube
Home/Beximco Pharmaceuticals/Dr. Ji‑yeon Kim
DJ

Dr. Ji‑yeon Kim

CSO

Beximco Pharmaceuticals

Therapeutic Areas

Metabolic DiseasesInfectious Diseases

Beximco Pharmaceuticals Pipeline

DrugIndicationPhase
BEX‑101Type‑2 Diabetes / ObesityPreclinical
BEX‑202COVID‑19 (SARS‑CoV‑2) InfectionPreclinical
BEX‑303Multidrug‑Resistant Bacterial InfectionsPreclinical

Leadership Team at Beximco Pharmaceuticals

DM
Dr. Min‑ho Lee
CEO
View full Beximco Pharmaceuticals profile